article How next-generation sequencing is opening the door for drug discovery 13 September 2017 | By Kim Judge The Wellcome Trust Sanger Institute's Kim Judge explains how Next Generation Sequencing forms a crucial part of the scientist’s toolkit and makes a valuable contribution to the field of drug discovery...